@FierceMedDev: Acutus hauls in $21M for a-fib imaging. Article | Follow @FierceMedDev
@DamianFierce: Not to be outdone by J&J, Medtronic is starting an artificial pancreas study of its own. News | Follow @DamianFierce
@MichaelGFierce: EnteroMedics files with FDA despite obesity-device trial flop. News | Follow @MichaelGFierce
> Canada's LifeLabs Medical Laboratory Services has agreed to buy diagnostics provider CML Healthcare for about $1.2 billion. Article
> BioFire Diagnostics won FDA clearance for its FilmArray Blood Culture Identification panel, a 27-target test for blood pathogens. News
> Valeant ($VRX) is sweetening the terms on its proposed bond sale, looking to lure investors and close its planned $8.7 billion buyout of Bausch + Lomb. Story
> Roche's ($RHHBY) Ventana Medical has partnered with the Translational Genomics Research Institute to find new cancer biomarkers and accelerate diagnostics development. More
> Aethlon Medical ($AEMD) has won the FDA's blessing to study its Hemopurifier device, designed to treat hepatitis C. Item
> Teleflex ($TFX) has inked a new deal with group purchaser HealthTrust to distribute its LMA line of laryngeal masks. Release
Biotech News
@FierceBiotech: Astellas bites off $490M deal to develop muscle drugs with Cytokinetics. News | Follow @FierceBiotech
@JohnCFierce: Bayer beefs up cancer drug pipeline with $520M armed antibody deal with Seattle Genetics. Story | Follow @JohnCFierce
@RyanMFierce: Where were the breakthrough drugs for diabetes at 2013 ADA? Report | Follow @RyanMFierce
> Isis steals diabetes drug spotlight with new approach to slashing blood fat. More
> Glaxo's diabetes drug fails to beat Takeda's Actos in head-to-head study. Report
> Takeda reorganizes top leadership, corporate structure. Item
Pharma News
@FiercePharma: Eisai pulls seizure drug Fycompa in Germany to protest "appalling" pricing decision. Article | Follow @FiercePharma
@EricPFierce: Impax CEO Larry Hsu, whose company has been sidetracked by FDA manufacturing issues, is retiring. Story | Follow @EricPFierce
@CarlyHFierce: GSK CEO Andrew Witty's M&A aim: Sell more, buy less. Story | Follow @CarlyHFierce
> Merck wins Indian injunction against Januvia copycats. Item
> U.S. Supreme Court protects generic drugmakers in 5-4 ruling. News
> Ranbaxy reportedly has FDA issues at Mohali. More
Biotech Research News
@EmilyMFierce: Lack of gene could predict earlier onset, severity of multiple sclerosis. Article | Follow @EmilyMFierce
> RNA molecule could reduce fat in bloodstream, regulate high cholesterol. More
> New target could be key to preventing epilepsy. Article
> Virus combo kills brain tumor cells in preclinical model. Story
> Penn scientists create human-cell model of pancreatic cancer. Article
> Antioxidant improves motor functions in mice with Parkinson's. Item
Pharma Manufacturing News
> India court quashes lawsuit against Ranbaxy plants. Item
> Pfizer quells fears of cuts at Ireland plant that makes Viagra. More
> Impax to get new CEO as it tries to right manufacturing issues. Article
> U.S. gets EU waiver on APIs in the nick of time. Story